Projects per year
Personal profile
Research interests
Miller Lab Consortium. To date, our team has treated more than 400 patients with natural killer cell infusions and over a hundred patients with therapies that activate their own natural killer cells. We've retrospectively analyzed more than 5000 patients and enrolled more than 500 patients in prospective trials.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Targeting off-the-shelf iPSC-derived natural killer cells against solid tumors
Miller, J. S., Antonarakis, E., Chen, C. C., Cichocki, F. M., Davis, Z. B., Dehm, S. M., Felices, M., Luo, X. & Provenzano, P.
NIH NATIONAL CANCER INSTITUTE (NCI)
8/1/23 → 7/31/30
Project: Research project
-
Off-the-Shelf Immune Effector Cells for Hematological Malignancies
Wagner, J. E., Bachanova, V., Betts, B., Brunstein, C. G., Cichocki, F. M., De For, T. E., Eaton, A., Hippen, K. L., Luo, X., Maakaron, J., McKenna, D. H. & Tolar, J.
NIH NATIONAL CANCER INSTITUTE (NCI)
5/5/23 → 4/30/28
Project: Research project
-
Bcl11b: A Master Transcription Factor Controlling Human NK Cell Development
Cichocki, F. M., Eaton, A., Felices, M. & Wang, J.
NIH NAT'L HEART, LUNG, AND BLOOD INSTITU
7/1/21 → 4/30/26
Project: Research project
-
NK cells, their receptors, and cancer therapy
Miller, J. S., Bachanova, V., Basu, S., Brunstein, C. G., Cichocki, F. M., Felices, M., Geller, M. A., Grzywacz, B. J., Le, C. T., Luo, X., Starr, T., Walcheck, B., Warlick, E. D. & Weisdorf, D. J.
NIH NATIONAL CANCER INSTITUTE (NCI)
4/9/21 → 3/31/26
Project: Research project
-
Development of NK Cell Therapeutics
Miller, J. S., Cichocki, F. M. & Felices, M.
1/1/20 → 12/31/22
Project: Research project
-
Engineered and banked iPSCs for advanced NK- and T-cell immunotherapies
Cichocki, F., van der Stegen, S. J. C. & Miller, J. S., Feb 23 2023, In: Blood. 141, 8, p. 846-855 10 p.Research output: Contribution to journal › Review article › peer-review
Open Access5 Scopus citations -
Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphoma
Cichocki, F., Zhang, B., Wu, C-Y., Chiu, E., Day, A., O’Connor, R. S., Yackoubov, D., Simantov, R., McKenna, D. H., Cao, Q., Defor, T. E., Janakiram, M., Wangen, R., Cayci, Z., Snyder, N., Kumar, A., Grzywacz, B., Hwang, J., Geffen, Y., Miller, J. S., & 2 others , 2023, In: Science Translational Medicine. 15, 705, eade3341.Research output: Contribution to journal › Article › peer-review
-
NK Cells from Human Cytomegalovirus Seropositive Individuals Have a Distinct Metabolic Profile That Correlates with Elevated mTOR Signaling
Lozada, J. R., Zhang, B., Miller, J. S. & Cichocki, F., Aug 2023, In: Journal of Immunology. 211, 4, p. 539-550 12 p.Research output: Contribution to journal › Article › peer-review
-
Process engineering of natural killer cell-based immunotherapy
Motallebnejad, P., Kantardjieff, A., Cichocki, F., Azarin, S. M. & Hu, W. S., Oct 2023, In: Trends in biotechnology. 41, 10, p. 1314-1326 13 p.Research output: Contribution to journal › Review article › peer-review
1 Scopus citations -
Adaptive single-KIR + NKG2C + NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia
Haroun-Izquierdo, A., Vincenti, M., Netskar, H., Van Ooijen, H., Zhang, B., Bendzick, L., Kanaya, M., Momayyezi, P., Li, S., Wiiger, M. T., Hoel, H. J., Krokeide, S. Z., Kremer, V., Tjonnfjord, G., Berggren, S., Wikström, K., Blomberg, P., Alici, E., Felices, M., Önfelt, B., & 10 others , Nov 1 2022, In: Journal for ImmunoTherapy of Cancer. 10, 11, e005577.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations